Coordinated Response to Imported Vaccine-Derived Poliovirus Infection, Barcelona, Spain, 2019–2020
Dolores Álamo-Junquera
, Julieta Politi, Pere Simón, Romina Dieli-Crimi, Ricardo Pujol Borrell, Roger Colobran, Monica Martínez-Gallo, Magda Campins, Andrés Antón, Juliana Esperalba, Cristina Andrés, María Gema Codina, Eva Polverino, M. Rosa Narciso, Emilia Molinero, and Cristina Rius
Author affiliations: Public Health Agency of Barcelona, Barcelona, Spain. (D. Álamo-Junquera, J. Politi, P. Simón, E. Molinero, C. Rius); Parc de Salut Mar, Barcelona (J. Politi); Hospital Universitari Vall d'Hebron, Barcelona (R. Dieli-Crimi, R. Pujol Borrel, R. Colobran, M. Martínez-Gallo, M. Campins, A. Antón, J. Esperelba, M. Gema Codina, E. Polverino); Universitat Autònoma de Barcelona, Barcelona (R. Colobran, M. Martínez-Gallo, M. Campins, A. Antón, J. Esperelba, M. Gema Codina); Institut Català de la Salut, Barcelona (M.R. Narciso); Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Barcelona (C. Rius)
Main Article
Figure
Figure. Timeline of public health actions in response to an imported vaccine-derived poliovirus infection, Barcelona, Spain, 2019–2020. PID, primary immunodeficiency.
Main Article
Page created: March 16, 2021
Page updated: April 22, 2021
Page reviewed: April 22, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.